CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4440-4449

  Gaspari, Anthony A ^a,b,c   Burns, Robert ^a   Nasir, Adnan ^a,d   Ramirez, Diana ^a,e   Barth, Richard K ^a   Haidaris, Constantine G ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Univ of North Carolina Chapel Hill ^*  (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANDIDA ALBICANS; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; GENE OVEREXPRESSION; HELPER CELL; HISTOPATHOLOGY; IMMUNOGENICITY; IMMUNOMODULATION; KERATINOCYTE; MOUSE; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031661884     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.9.4440-4449.1998     Document Type: Article

References (54)

1. Ashman, R. B. 1990. Murine candidiasis: cell-mediated immune response correlates directly with susceptibility and resistance to infection. Immunol. Cell Biol. 60:15-20.
2. Burns, R., A. Nasir, B. Ferbel, D. Ramirez, R. Barth, and A. A. Gaspari, The T-cell costimuliitory molecules B7-1 (CD80) and B7-2 (CD86) when expressed on keratinocytes deliver different signals during contact hypersensitivity responses. J. Invest. Dermatol., in press.
3. Cantorna, M. T., and E. Balish. 1991. Role of CD4 + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455.
4. Casadevall, A. 1995. Antibody immunity and invasive infections. Infect. Immun. 63:4211-4218.
5. Cenci, E., L. Romani, A. Vecchiarelli, P. Puccetti, and E. Bistoni. 1989. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect. Immun. 57:3581-3587.
6. Cenci, E., L. Romani, A. Vecchiarelli, P. Puceetti, and F. Bistoni. 1990. T-cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice. J. Immunol. 144:4333-4339.
7. Cenci, E., A. Menacci, G. Del Sero, F. Bistoni, and L. Romani. 1997. Induction of protective Thl responses to Candida albicans by antifungal therapy alone or in combination with an interlcukin-4 antagonist. J. Infect. Dis. 176:217-226.
8. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
9. Dearman, R. J., A. Moussavi, D. M. Kemeny, and I. kimber. 1996. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89:502-510.
10. Diamantstein, T., R. Eckert, H. D. Volk, and J. W. Kupier-Wegtinski. 1988. Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anli-CD4 or anli-interleukin-2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+ Thl + subset in mice. Eur. J. Immunol. 18:2101-2103.
11. Domer, J. E., and S. A. Moser. 1978. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge. Infect. Immun. 20:88-98.
12. Elenitsas, R., P. Van Belle, and D. Elder. 1994. Laboratory methods, p. 51-60. In D. Elder, R. Elenitsas, C. Jaworsky, and B. Johnson, Jr. (ed.), Lever's histopathology of skin, 8th ed. Lippincott-Raven, Philadelphia, Pa.
13. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1993. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immun. 61:4202-1207.
14. Gaspari, A. A., R. P. Burns, Jr., S. Kondo, A. Nasir, A. Kurup, D. Mlodynia, D. Sauder, and R. K. Barth. 1998. Characterization of the altered cutaneous reactivity in transgenic mice whose keratinocytes overexpress B7-1. Clin. Immunol. Immunopathol. 86:259-270.
15. Gaspari, A. A., B. Ferbel, Z. Chen, F. Razvi, and R. Polakowska. 1993. Accessory and alloantigen presenting cell functions of A431 keratinocytes that stably express the B7 antigen. Cell. Immunol. 149:291-302.
16. Gaspari, A. A., M. K. Jenkins, and S. I. Katz. 1988. Class II MHC-bearing keratinocytes induce antigen-specific unrcsponsiveness in hapten-specific TH1 clones. J. Immunol. 141:2216-2220.
17. Gilman, M. 1993. Ribonuclease protection assay, p. 4.7.1-4.7.8. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stuhl (ed.). Current protocols in molecular biology, vol. 1. John Wiley and Sons, Inc., New York, N.Y.
18. Greenfield, R. A. 1992. Host defense system interactions with Candida. J. Med. Vet. Mycol. 30:89-104.
19. Haidaris, P. J., T. W. Wright, F. Gigliotti, and C. G. Haidaris. 1992 Expression and characterization of a cDNA clone encoding an immunodominant surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 166:1113-1123.
20. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
21. Hatchcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Modes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
22. Hoffman, M., and C. G. Haidaris. 1993. Analysis of Candida albicans adhesion to salivary mucin. Infect. Immun. 61:1940-1949.
23. Hoffman, M. P., and C. G. Haidaris. 1994. Identification and characterization of a Candida albicans binding proteoglycan secreted from rat submandibular salivary glands. Infect. Immun. 62:828-836.
24. Inaba, K., M. Inaba, M. Witmer-Pack, K. Hatchcock, R. Hodes, and R. M. Steinman. 1995. Expression of B7 costimulator molecules on mouse dendritic cells. Adv. Exp. Med. Biol. 378:65-70.
25. Inaba, K., M. Witmer-Pack, K. Hatchcock, H. Sakuta, M. Azuma, M. Yagita, K. Okumura, P. S. Linsley, and S. Ikehara. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
26. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321-331.
27. Kirkpatrick, C. H. 1989. Chronic mucocutaneous candidiasis. Eur. J. Microbiol. Infect. Dis. 8:448-456.
28. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
29. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Babavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155.
30. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
31. Lloyd, K. O. 1970. Isolation, characterization and partial structure of pep- tido-galactomannans from the yeast form of Cladosporium werneckii. Biochemistry 9:3446-3453.
32. Lu, P., Y. L. Wang, and P. S. Linsley. 1997. Regulation of self-tolerance by CD80/CD86 interactions. Curr. Opin. Immunol. 9:858-862.
33. Meitner, S. W., W. H. Bowen, and C. G. Haidaris. 1990. Oral and esophageal Candida albicans infection in the hyposalivatory rat. Infect. Immun. 58:2228-2236.
34. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Gredlin, and R. L. Coffman. 1986. Two types of murine helper T ceil clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 144:1472-1477.
35. Nabors, G. S., T. Nolan, W. Croop, J. Li, and J. P. Farrell. 1995. The influence of the site of parasite inoculation on the development of Thl and Th2 type immune responses in (BALB/c ′ C57BL/6)F1 mice infected with Leishmania major. Parasite Immunol. 17:569-579.
36. Nasir, A., B. Kerbel, W. Salminen, R. K. Barth, and A. A. Gaspari. 1994. Exaggerated and persistent cutaneous-delayed type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J. Clin. Invest. 94:892-898.
37. Naylor, M. S., M. Reif, and F. R. Balkwill. 1995. Northern analysis, ribonuclease protection and in situ analysis of cytokine messenger RNA, p. 35-56. In F. R. Balkwill (ed.), Cytokines. A practical approach. Oxford University Press, Oxford, England.
38. Nicholson, L. B., and V. K. Kuchroo. 1996. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:837-842.
39. Peat, S., W. J. Whelan, and T. E. Edwards. 1961. Polysaccharides of baker's yeast. IV. Mannan. J. Chem. Soc. 1:29-34.
40. Qian, Q., and J. E. Cutler. 1997. Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect. Immun. 65:1748-1753.
41. Rippon, J. W. 1988. Candidiasis and the pathogenic yeasts, p. 532. In J. W. Rippon (ed.). Medical mycology, vol. 3. W. B. Saunders, Philadelphia, Pa.
42. Romani, L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni. 1991. Thl and Th2 cytokine secretion patterns in murine candidiasis: association of Thl responses with acquired resistance. Infect. Immun. 59:4647-4654.
43. Romani, L., A. Mencacci, U. Grohmann, S. Mocci, P. Mosci, P. Puccetti, and F. Bistoni. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper lype 1-associated immunity in murine candidiasis. J. Exp. Med. 176:19-25.
44. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti, and F. Bistoni. 1993. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:925-931.
45. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, G. Del Sero, I. Nicoletti, G. Trinchieri, F. Bistoni, and P. Puccetti. 1997. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:5349-5356.
46. Sambrook, J., C. G. Romball, M. V. Hobbs, D. N. Ernst, L. Shultz, and W. O. Weigle. 1996. CD4+ T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339-1344.
47. Saulnier, M., S. Huang, M. Aguet, and B. Ryffel, 1995. Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice. Toxicology 102:301-312.
48. Sohnle, P. G., and B. L. Hahn. 1989. Effect of immunosuppression on epidermal defenses in a murine model of cutaneous candidiasis. J. Lab. Clin. Med. 113:700-707.
49. Sohnle, P. G., and B. L. Hahn. 1989. Epidermal proliferation and the neutrophilic infiltrates of experimental cutaneous candidiasis in mice. Arch. Dermatol. Res. 281:279-283.
50. Sohnle, P. G., and B. L. Hahn. 1992. The fate of individual organisms during clearance of experimental cutaneous Candida albicans infections in mice. Acta Dermato-Venereol. 72:241-244.
51. Strelein, J. 1978. Lymphocyte traffic, T-cell malignancies and the skin. J. Investig. Dermatol. 71:167-171.
52. Vasilas, A., L. Molina, M. Hoffman, and C. G. Haidaris. 1992. The influence of morphological variation on Candida albicans adhesion to denture acrylic in vitro. Arch. Oral Biol. 37:613-622.
53. Williams, I. R., R. J. Ort, and T. S. Kupper. 1994. Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc. Natl. Acad. Sci. USA 91:12780-12784.
54. Willis, I., and A. M. Kligman. 1968. The mechanism of the persistent light reactor. J. Investig. Dermatol. 51:385-394.